Speakers

speakers for second international conference

mathieu

Prof. Mathieu Vinken

Prof. Mathieu, Pharm.D., Ph.D. is the Faculty at Vrije Universiteit Brussel-Belgium, and a visiting professor at the University of São Paulo-Brazil. He is a European Registered Toxicologist (E.R.T.). He is the past-President of the European Society of Toxicology In Vitro. He works in the field of in vitro toxicology and in the area of experimental hepatology. He is promoter of 6 completed PhD projects and 3 finalized postdoctoral projects. He is author of more than 180 publications in international peer-reviewed journals. He is editor of 3 books. He is editor-in-chief of few reputed journals. He is a regularly invited speaker on international conferences. He is member of various expert panels. He coordinates several (inter)national research projects and received a number of scientific awards.

Dr. Helena Kandarova

Dr. Helena Kandarova, is a Senior Scientist in In Vitro Toxicology at the Centre for Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia. Dr. Helena is a European Registered Toxicologist (E.R.T.). She is the current President of the European Society of Toxicology In Vitro, Vice-president of SETOX, Chair of the Slovak National Platform for 3Rs (SNP3Rs). She has over 50 Scientific Papers, 9 Book chapters and over 600 Conference Presentations (posters and oral presentations) for her credit. She has delivered key note speeches at international 3R Events. She is on the editorial board of few prestigious journals and is a scientific reviewer for few more journals.

luiza

Dr. Ana Luiza Garcia Massaguer Millas

Dr. Ana Millás is a biologist, with a postdoctoral degree from the School of Pharmaceutical Sciences at USP/São Paulo, a PhD in Materials and Bioprocess Engineering and a master’s degree in Polymer Technology from the School of Chemical Engineering at UNICAMP. She carried out part of her research in renowned centres and institutions, including Cornell University in the United States, Nottingham Trent University, and The Electrospinning Company in England.

adedamula

Dr. Adedamola (Dammy) Olayanju

Dr. Adedamola (Dammy) Olayanju is the Principal Scientist for Manchester BIOGEL. Dr. Dammy’s work focuses on the development and application of fully defined synthetic peptide hydrogels in Regenerative Medicine, Tissue engineering and robust in vitro 3D platforms such as the organoid technology for drug screening and development. As the company’s technical expert, he offers support and training programs in 2D and 3D cell cultures for customers, the wider community and also contributes to the development of external scientific projects.
Prior to joining Manchester BIOGEL, Dr. Dammy was a Senior Research Scientist at Northwick Park Institute for Medical Research (NPIMR), London. He also gained postdoctoral training and his PhD in Pharmacology and Therapeutics at the University of Liverpool, UK.

leticia

Ms. Letícia Charelli

Ms. Letícia Charelli is the Educational Technology coordinator at 3D Biofabrication Training and Innovation Center, (BioEdTech), a startup founded in 2018, located in São Paulo, Brazil which is spreading bioprinting technology so that researchers do not use animals for research.

Ms. Letícia has Bachelor’s degree in Biotechnology from Universidade Federal do Rio de Janeiro and a Masters in biotechnology from INMETRO – National Institute of Metrology, Quality, and Tecnology, with an emphasis on bio fabrication techniques, (3D cell culture and microfluidics). She is researcher with more than seven years of experience in primary cell culture, adipose-derived mesenchymal stem cells isolation, and 3D cell culture for tissue engineering and compound analysis. From past two years she has been working with organ-on-chip devices for 3D cell culture. Currently, she is developing optimized protocols for 3D bioprinting of heterogeneous and robust tissue-like constructs. Currently, she dedicates her time to develop optimized protocols for the biofabrication of organotypic on-chip devices and their validation as a reliable alternative method. Her main interests include Bioprinting technology, organ-on-chip, organotypic cell culture, and nanomedicine. She is an aspiring entrepreneur, seeking to translate the product from the bench to the bedside.

tuli dey

Dr. Tuli Dey

Dr. Tuli Dey is an assistant professor at Savitribai Phule Pune University. She is interested in developing an efficient and cost-effective platform to study tumor biology in vitro. In addition, she is passionate about creating a human-relevant disease model to reduce animal models from the research laboratories. She has completed her doctoral study (IIT Kharagpur) on cell and molecular biology and gained experience in biomaterials and disease biology modeling during her postdoc tenures (FAU Germany, IIT Kharagpur).

manish gore

Manish Gore

Manish Gore is currently pursuing Integrated PhD in Bioprocess Technology at the Institute of Chemical Technology, Mumbai, India. Earlier, he obtained his undergraduate degree in Pharmaceutical Sciences from the Institute of Chemical Technology, Mumbai, India. He is interested in developing physiologically relevant in-vitro models of human tissues/organs for preclinical and biomedical applications using three-dimensional cell culture methods and microfluidic technology.

ahuluwalia

Dr. Arti Ahluwalia

Dr. Arti Ahluwalia is currently the Full Professor of Bioengineering at the Dept. of Information Engineering and Director of the Research Center for Bioengineering and Robotics “E. Piaggio “, University of Pisa, the Director of the Centro3R, Italian Interuniversity Center for the promotion of the 3Rs in research and teaching. Dr. Arti is also co-Head of the NanoBioscopy Laboratory (a joint laboratory between the Piaggio Center and the Dept. of Biology of the University of Pisa) dedicated to Imaging and Microscopy. She is author of more than 100 scientific publications and 14 patents on microfabrication techniques and bioreactors. Her research has always maintained a high level of interdisciplinarity, being based on her knowledge of physics, mathematics, biology, and analytical and measurement sciences, applied to bioengineering. The underlying theme is the study of biomimetics and interaction between the biological and artificial worlds for the realization of bio-hybrid in vitro systems through the integration of engineering technologies (biomaterials, fluid systems, microscopy, biomechanics, biosensors, computational models). She has coordinated and participated in numerous competitive projects on the development of human resources, tissue engineering, biomaterials, biosensors and bioreactors. The outcomes of her research have been translated to commercial products through two companies, one of which she has cofounded.

mandarkulkarni

Dr. Mandar Kulkarni

After earning his doctorate in molecular carcinogenesis from Purdue University, Dr. Mandar Kulkarni was selected to become a T32 fellow at the Yale School of Medicine and was awarded a young scientist award for his work in the structural biology and signal transduction. As a senior scientist at M/Z Diagnostics, he managed business, obtained an NIH-SBIR grant as a PI, and was awarded a Young scientist award by the FSG. At Sandor Lifesciences, as the Head of Molecular Biology and Genomics, he designed and executed numerous NGS, microarray and bioinformatics projects. Then, as the Chief Technology Officer at CGIndia, he managed all operations and lead the development of research services, diagnostics, biopharma services, R&D, and genomics-based clinical assays in the area of precision oncology. He was also responsible for ensuring the financial success of the Indian business unit and established several high value collaborations in the Indian personalized oncology space. Currently, he is also a key member of the senior executive team and drives the scientific agenda at Lumiseek.

jaganmohan

Dr. Jaganmohan Reddy

Dr. Jaganmohan Reddy is currently a CEO and CSO of UR Advanced Therapeutics Pvt Ltd, a startup organization working in the areas of Tissue Engineering, Biomaterials and cancer biology. He worked as a Visiting Scientist and as a Senior Researcher at Linkoping University post PhD before moving to India to establish his own laboratory. He has published 18 high impact peer reviewed articles, book chapters and holds a world patent on Artificial Cornea. He has trained several Masters and sponsored 3 PhD students. He has served as a reviewer, guest editor for several journals. Dr. Reddy presented his works in several invited talks at international conferences including TERMIS-AP 2019 and universities. He also served as a program organizing committee chair and scientific advisory committee for TERMIS EU2016 and chaired sessions during the conferences.

pushkar

Dr. Pushkar Kulkarni

Dr. Pushkar Kulkarni is a veterinarian by training, PhD in pharmacology & toxicology and a Diplomat of the American Board of Toxicology (DABT). Presently, he is working as a Senior Research Scientist at Dr. Reddy’s Institute of Life Sciences (DRILS), Hyderabad where he has set up a zebrafish laboratory from scratch. His past record includes working at Ranbaxy Laboratories, Gurgaon and GVK Bio, Hyderabad. He has got entrepreneurial experience as Co-founder & Director of two start-ups: Zephase Therapeutics (zebrafish services company) and Vegrandis Therapeutics (nanotechnology company). He has filed two international patents and published 45 research papers (including 1 book chapter) in reputed peer reviewed journals that have been cited around 750 times till date, with several of them been cited by Key Opinion Leaders in the field.

IMG-20201110-WA0010

Dr. Montip Gettayacamin

Dr. Montip Gettayacamin is Senior Director for Southeast Asia at AAALAC International, a position she has held for the past eleven years. In this role she supports AAALAC International’s accreditation program to advance research animal welfare in the region and assists institutions to attain accreditation. Dr. Montip received her veterinary medicine degree from Chulalongkorn University, Bangkok, Thailand in 1984. She is a Diplomate of the American College of Laboratory Animal Medicine. She has over 30 years of experience in Laboratory Animal Medicine and previously served as Assistant Chief for Research and Laboratory Animal Medicine, and Senior Research Scientist at Department of Veterinary Medicine, United States Army Medical Component, Armed Forces Research Institute of Medical Sciences (USAMC-AFRIMS), Bangkok, Thailand. The program has attained AAALAC International accreditation since 1999. She has authored and coauthored more than 50 scientific publications. She translated the Guide for the Care and Use of Laboratory Animals, National Research Council (NRC, 1996 and 2011), the Occupational Health and Safety in the Care and Use of Research Animals (NRC, 1997) and the Guide for the Care and Use of Agricultural Animals in Research and Teaching (FASS 2010) to Thai. Dr. Montip is a reviewer of Journal of Visualized Experiments (JoVE) and a member, Editorial Board, Animal Models,and Experimental Medicine (AMEM) Journal. She is a former member of AAALAC International Council on Accreditation. She has served on International Council for Laboratory Animal Science (ICLAS) Governing Board and the Chair of Asia Regional Committee for 2019-2023. Dr. Montip is the Chair of the Educational and Scientific Program Committee, AFLAS Congress 2020.

Dr. Uday Saxena

Dr. Uday Saxena is Co-Founder and Chief Ideator of Reagene Biosciences. He was “Mentor –in-Residence” and Professor of Translational Research at Dr.Reddy’s Institute of Life Sciences as well as Co-Founder of start-up Biotech Company. He has held Executive and Leadership positions at Parke-Davis, AtheroGenics, Dr.Reddy’s Laboratories and Kareus Therapeutics. He is responsible for leading teams that brought several drug candidates from idea into the clinic. He likes to use “disruptive science” to discover and understand new therapies.

akshaysonawane

Mr. Akshay Sonawane

Mr. Akshay is Research Scientist at Oncoseek Bio. He is Double masters in Biotechnology from Pune University. His interest is in creating spheroids as disease models for various solid cancers, NASH, NAFLD, and few other infectious and metabolic diseases. He has experience of creating spheroid models for breast cancers earlier. He has 2 book chapters for his credit.

speakers for first international conference

IMG-20200210-WA0017

Dr. Marcel Gyger

Marcel Gyger is currently the Member of the Scientific Board of the Fondazione Guido Bernardini, Chair of the FELASA Accredition Board for Education and Training, FELASA Vice-President for Education and Training, present Hon. Secretary of ETPLAS (European Education and Training Platform for Laboratory Animal Science) and Head of the animal facilities of Campus Biotech Geneva, Switzerland. Marcel is an Ethologist and has worked extensively in the field of bioacoustics and communication in Rodents and Birds. He obtained his Ph. D. in Physiology from the University of Lausanne and later had a Post-Doc training at Rockefeller University, NYC, USA.

Charu Chandrasekera

Charu Chandrasekera, is currently the Executive Director at Canadian Centre for Alternatives to Animal Methods, Ontario, Canada. Charu who hails from srilanka, is an experienced biochemist/molecular biologist, former animal researcher, and science policy expert who advocates for higher standards in biomedical research and a paradigm shift in which our species, Homo sapiens, serves as the quintessential animal model and our biology is the gold standard in biomedical research, education, and regulatory testing through 21st century science, innovation, and ethics.

IMG-20200129-WA0018

S Dravida

S Dravida, Founder and CEO of Transcell Group, leads their product portfolio www.transtoxbio.com that has all new league of human surrogate in vitro systems with innate powers to predict safety and potency of drug/vaccine/cosmetics candidates being trialed for human applications. Through this vertical-specific offering her company adds value in understanding pharma assets better and on the most relevant preclinical systems that require no extrapolation to human applications.

Dr. Uday Saxena

Dr. Uday Saxena is Co-Founder and Chief Ideator of Reagene Biosciences. He was “Mentor –in-Residence” and Professor of Translational Research at Dr.Reddy’s Institute of Life Sciences as well as Co-Founder of start-up Biotech Company. He has held Executive and Leadership positions at Parke-Davis, AtheroGenics, Dr.Reddy’s Laboratories and Kareus Therapeutics. He is responsible for leading teams that brought several drug candidates from idea into the clinic. He likes to use “disruptive science” to discover and understand new therapies.

IMG-20200129-WA0017

Dr. Subrahmanyam Vangala

Dr. Subrahmanyam Vangala  is the founder and CEO of ReaGene Biosciences Private Limited. He is an experienced pharma scientist and executive with more than two decades of leadership experience at global pharma in USA (Wyeth, JNJ., Purdue Pharma and Shire) and Contract Research Organizations in India (Sai Life and Advinus). He brings with him, unique insights into providing cost effective alternative solutions for substituting animal studies for regulatory products. He received his PhD in Biochemistry from Memorial University, Canada and postdoctoral experience at University of Colorado at Boulder and University of California at Berkeley.

IMG-20200924-WA0002

Prof. Thomas Hartung

Professor Thomas Hartung is currently the Director of the Center for Alternatives to Animal Testing (CAAT) at The Johns Hopkins University Bloomberg School of Public Health Baltimore. He is a professor of Molecular Microbiology and Immunology (Joint) and a Professor of Evidence-Based Toxicology. The main goal of his research is towards a paradigm shift in toxicity testing to improve public health. His experience in clinical and experimental pharmacology and toxicology has been documented in more than 550 publications. His previous work centered on the immune recognition of bacteria, including pyrogen testing, and the induced inflammatory response. He has an active lab that is involved in research on developmental neurotoxicity based on genomics and metabolomics.  He has many honors and awards like the Research Award for replacing animal experiments from the German Ministery of Health and the European F.I.S.E.A. Foundation, Luxembourg, Doerenkamp/Zbinden Award for replacement of animal experiments, Sandoz Award for therapeutically relevant pharmacological research, Business Innovation Award of the region lake Konstanz for the development of an alternative pyrogen test, RIVM Award at the World Conference on Animal Use and its Alternatives, US Society of Toxicology Enhancement of Animal Welfare Award, Russell & Burch award of the Humane Society of the US, Agilent Thought Leader award, EuroGroup for Animals – Animal Welfare Award, Björn Ekwall Memorial Award of the Scandinavian Society for Cellular Toxicology to name a few.

IMG-20200129-WA0038

Dr. Lars Friis Mikkelsen

Dr. Lars Friis Mikkelsen is the CEO of Ellegaard Göttingen Minipigs in Denmark. In 1994, he received his veterinary (DVM) degree from the Royal Veterinary and Agricultural University in Denmark and in 2007, he received his Master´ in Laboratory Animal Science (MLAS) degree from the University of Copenhagen. Furthermore, he received an Executive MBA degree from the National University of Singapore in 2014.
 
Lars has a unique international educational and professional background combining science and business with a vision of making a difference for the society, the patients and the animals being used in research. His passion for combining science and business have led to a number of board memberships in international organizations plus numerous peer-reviewed publications in well-recognized journals, and he is a well-known and often invited speaker at international scientific meetings and conferences sharing his scientific interests, knowledge and experience.
 
In addition, Lars founded LarSolution in 2014; offering support and solution for in vivo pharmacological research and business development, professional advice on laboratory animal care and use as well as guidance on animal welfare, health and veterinary related issues; all servicing the scientific community in the spirit of the 3Rs Principles; and all through the company’ vision of implementing the LFM Principles of Leveraging, Fulfilling & Managing business operating in the best LarSolutionable way.
IMG-20201021-WA0012

Victoria Sachs

Victoria Sachs is currently an Animal Use Trainer for The Jackson Laboratory residing in the Sierra Nevada foothills of California. She holds a Bachelor’s of Science from the University of California, Davis in Animal Science and is responsible for educating animal care technicians and animal researchers on proper animal handling and biomethods focusing on the excellent and ethical treatment of mice in animal research. She also has extensive experience producing and caring for a variety of humanized mouse models and conducting applicable studies focusing on acute myeloid leukemia (AML), immunotoxicity, oncology and graft versus host disease (GvHD). 
IMG-20201021-WA0011

Dr. Brenda Kick

Dr. Brenda Kick is currently a Senior Clinical Veterinarian at The Jackson Laboratory, Bar Harbor, Maine campus. She obtained her veterinary degree from Colorado State University and completed a laboratory animal medicine specific residency at Emory University in Atlanta, Georgia. She has worked with laboratory animals since 2006, with much of her experience working with non-human primates and mice. Her career interests include improvements for laboratory animal welfare and humane endpoints, aging mice colony care, and refinements to animal use.

IMG-20201014-WA0010

Dr. Ritu Verma

Dr. Ritu is a leading cell biologist with a Ph.D. in Biotechnology from IIT Delhi and associated with Dabur Research Foundation for over 16 years. She is currently heading preclinical operations and is responsible for overall strategy and coordination for different projects. She has wide experience in cell-based animal-free models in different therapeutic areas such as oncology, metabolic disorders, immunity, inflammation, dermatology, dermal pathologies amongst others. She has expertise in designing a roadmap strategy for a wide range of products in compliance with various requirements as per project need.

IMG-20201110-WA0010

Dr. Montip Gettayacamin

Dr. Montip Gettayacamin is Senior Director for Southeast Asia at AAALAC International, a position she has held for the past eleven years. In this role she supports AAALAC International’s accreditation program to advance research animal welfare in the region and assists institutions to attain accreditation. Dr. Montip received her veterinary medicine degree from Chulalongkorn University, Bangkok, Thailand in 1984. She is a Diplomate of the American College of Laboratory Animal Medicine. She has over 30 years of experience in Laboratory Animal Medicine and previously served as Assistant Chief for Research and Laboratory Animal Medicine, and Senior Research Scientist at Department of Veterinary Medicine, United States Army Medical Component, Armed Forces Research Institute of Medical Sciences (USAMC-AFRIMS), Bangkok, Thailand. The program has attained AAALAC International accreditation since 1999. She has authored and coauthored more than 50 scientific publications. She translated the Guide for the Care and Use of Laboratory Animals, National Research Council (NRC, 1996 and 2011), the Occupational Health and Safety in the Care and Use of Research Animals (NRC, 1997) and the Guide for the Care and Use of Agricultural Animals in Research and Teaching (FASS 2010) to Thai. Dr. Montip is a reviewer of Journal of Visualized Experiments (JoVE) and a member, Editorial Board, Animal Models,and Experimental Medicine (AMEM) Journal. She is a former member of AAALAC International Council on Accreditation. She has served on International Council for Laboratory Animal Science (ICLAS) Governing Board and the Chair of Asia Regional Committee for 2019-2023. Dr. Montip is the Chair of the Educational and Scientific Program Committee, AFLAS Congress 2020.

IMG-20201110-WA0011

Bryan E. Ogden

Bryan E. Ogden is Director of the SingHealth Experimental Medicine Centre and the National Large Animal Research Facility, as well as Adjunct Associate Professor at Duke-NUS Medical School in Singapore.  He is a member of Singapore’s National Advisory Committee for Laboratory Animal Research and founding past-President of the Singapore Association for Laboratory Animal Science (SALAS). Dr. Ogden earned his veterinary degree from the University of Minnesota in 1980.  Prior to beginning his career in laboratory animal medicine, Dr. Ogden worked eight years in private veterinary practice, including farm animals, pets, and critical care. He has served on 12 different IACUCs during his career. His previous positions have included: Director, Veterinary Services, Maccine Pte. Ltd.; Animal Resources Division Head and Assistant Director, Oregon National Primate Research Center; and Associate Director, Department of Comparative Medicine and Clinical Professor, Oregon Health & Science University.  He is a Diplomate in the American College of Laboratory Animal Medicine and currently serves as a Council Member Emeritus for AAALAC International.
IMG-20201110-WA0012

Dr. Dewi Rowlands

Dr. Dewi Rowlands is Director, Centre for Comparative Medicine Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of China. Dr. Rowlands received a doctorate degree in Physiology and a master of philosophy degree in Pharmacology from The Chinese University of Hong Kong, and a master’s degree in business administration from the University of Sunderland, United Kingdom. He has expertise in development of animal research models of pain, reproductive and degenerative diseases, together with experience in management and development of animal care and use programs in teaching and research.  Dr. Rowlands currently serves as Chairperson of the Legal Sub-Group and as a Member of the Animal Welfare Advisory Group of the Hong Kong Government and founding President of the Hong Kong Laboratory Animal Sciences Society.  He currently serves as a member of AAALAC International Council on Accreditation.
IMG-20200129-WA0023

Dr. Manjunath Ramarao

Dr. Manjunath Ramarao is the Executive Director, Site Leader, Research and Early Development, BBRC and Head of Discovery Biology and Translational Medicine, BBRC at Bristol-Myers Squibb. He leads a large team of scientists involved in drug discovery research efforts spanning diverse areas including in vitro biology, mechanistic biochemistry, genomics, protein sciences, biophysics, crystallography, electrophysiology, computational biology, compound management and automation. He joined BMS in 2009 after an industrious career at Wyeth, Cambridge, MA, USA, which spanned over eight years where he initiated and successfully led several drug discovery programs. Prior to that he worked as an Instructor in Neurobiology at Harvard Medical School, Boston, MA, USA. He holds Ph.D. and MS in Physiology from the University of Illinois at Urbana-Champaign, USA and MSc (Biochemistry) and B.Sc. from Bangalore University, India.

IMG-20200921-WA0002

Dr. Vijay Pal Singh

Dr. Vijay Pal Singh is currently the Joint Director (Social and Behavioural Change & AMR) in the Food Safety and Standard Authority of India (FSSAI), Govt of India. Earlier he served as an Assistant Professor in the Academy of Scientific and Innovative Research (AcSIR). Dr. Singh is a Graduate in Veterinary Medicine, Postgraduate in Dairy Husbandry and milk processing and a Doctorate in Biotechnology. He has 36 indexed research articled.

IMG-20200129-WA0014

Dr. Balaji Bhyravbhatla

Dr. Balaji Bhyravbhatla, is the Managing Director at HyLasCo Bio-Technology (India) Pvt. Ltd. Dr. Balaji, after his Ph.D in Biophysics from Brandies University started his career as post doc in Florida state University and later remained as a visiting faculty member in the Institute of Molecular Biophysics and played major role in facilities planning, setting up of infrastructure as well as training programs. Later, in 2001 he joined as faculty in University of Massachusetts medical school and instrumental in starting the research core in structural biology and training programs in structural biology in the Dept. of Biochemistry and Molecular Biology. He continued his research on large protein structures and mechanisms of oxygen transport using haemoglobin from various species as well as computational methods for solvent models and ligand binding. His technical expertise in early stage drug discovery and mechanism of action studies, small molecule characterization and API developments, analyzing patents and formulating IP strategies led him to co found XTAL Biostructures for structure guided drug discovery services. He led XTAL from its inception, first as VP for research and later as its CEO to a multimillion dollar self funded organically growing company. Recently he stepped down as the CEO of XTAL to start Hylasco Biotechnology in 2012 partnering with internationally reputed manufactures and suppliers of animal models and related services. His vision is to bring down the cost of drug discovery by providing appropriate animal models in a cost effective way to the Indian Pharma and Biotech sectors.

IMG-20200922-WA0025

Dr. Avery August

Dr. Avery August is a Professor and former Chair of the Department of Microbiology and Immunology at Cornell University, Ithaca, New York. He is currently HHMI Professor and Vice Provost for Academic Affairs. His previous position was as Distinguished Professor of Immunology in the Department of Veterinary & Biomedical Sciences, and Director of the Center for Molecular Immunology & Infectious Disease, at The Pennsylvania State University at University Park, where he started as an Assistant Professor in 1999. He received a B.S. degree in Medical Technology from the California State University at Los Angeles, and a Ph.D. degree in Immunology from the Weill Cornell Graduate School of Medical Sciences. He was a Postdoctoral fellow at The Rockefeller University with the late Hidesaburo Hanafusa. His research interests include regulation of immune response by intracellular signaling events, CD8+ T cell memory development, and production of inflammatory and anti-inflammatory cytokines by CD4+ and CD8+ T cells during lung inflammation or infection.

IMG-20200922-WA0004

Dr. Christian PELLEVOISIN

Dr. Christian PELLEVOISIN is currently the Scientific Director at EPISKIN, a subsidiary of L’Oreal, dedicated to the development and production of reconstructed human epithelia for safety and efficacy assessment of chemical, cosmetics, drugs and medical devices. Engaged in projects that led to the introduction of new models and methods to the market, Dr. Chris also developed the EPISKIN Academy program to promote alternative methods through education and training. He is involved for several years in the biocompatibility of medical devices. He is the chairman of the French AFNOR S92J commission for biocompatibility of medical devices and convenor of the ISO/TC 194/WG8 skin irritation and sensitization.

IMG-20200129-WA0016

Prof P.V.S. Kishore

Dr. P.V.S. Kishore is the Professor & Head of the Department of Veterinary Anatomy, College of Veterinary Science, Gannavaram in India. He completed the Animal Welfare Training Course sponsored by RSPCA in 1992 and was appointed as the Honorary Animal Welfare Officer, Animal Welfare Board of India for the period from 1992-1997. He was the recipient of the ‘Humane Education Award 2003’ from the International Network for Humane Education, England. He is the CPCSEA Nominee/Inspector of Government of India since August 2009. He established the ‘Willed Body Programme in Veterinary Education’ the first of its kind in the country. He organized one National Workshop on ‘Willed Body Programme and Humane Alternatives for Laboratories in Veterinary Education’. He was the pioneer in the country to start an Anatomy youtube channel ‘Willed Body Programme’. He pioneered the development of the innovative teakwood anatomy educational models. He guided many post-graduate scholars for research works on laboratory animals. He is presently undertaking a DST project on bone regeneration in rats.

IMG-20201021-WA0010

Dr. Brian W. Soper

Dr. Brian W. Soper, is the Manager and Senior Technical Information Scientist at Technical Information Services which provides educational resources to the scientific community. Dr. Soper has worked at The Jackson Laboratory for more than 25 years. He has conducted research on hematopoietic stem cell biology, bone marrow transplantation, immune tolerance and treatment strategies for a mouse model of human enzyme deficiency.  Brian’s expertise includes the immuno-biology of humanized mice following human PBMC or hematopoietic stem cell transplantation, and their use to study human immune modulation and immuno-oncology when co-transplanted with human tumors.

Franco Mondini

Franco  Mondini is currently the International Sales Director of Tecniplast, Italy. Tecniplast is the world leading company in the Lab Animal Industry in designing, manufacturing and distributing patented equipment for laboratory animals since 1949.

IMG-20200929-WA0000

Dr. Tharanga Thoradeniya

Dr. Tharanga Thoradeniya obtained her Bachelor of Veterinary Science (B.V.Sc) degree from the Faculty of Veterinary Medicine and Animal Science, University of Peradeniya, Sri Lanka and her Ph.D. in Nutritional Biochemistry from the University of Colombo, Sri Lanka.

Dr. Thoradeniya is a vibrant advocate for science and particularly for young scientists and women in science. She is the past president of the Sri Lanka Association for Laboratory Animal Sciences (SLALAS) (2017/18) and Sri Lankan Academy of Young Scientists (2016/17). In addition, she is actively contributing to the Sri Lanka Veterinary Association (current Assistant secretary), Sri Lanka College of Biochemists (founder co-secretary and current vice-president), Sri Lanka National Chapter for Organization for Women in Science in the Developing world (OWSD) (founder treasurer).

She has conducted animal ethics and welfare trainings nationally and internationally. As the Secretary and current chairperson of the Animal Research Welfare Sub Committee at the Faculty of Medicine, Colombo and a member of the Bioethics Committee of the National Science Foundation of Sri Lanka (2018), she is playing a leading role in developing consensus guidelines for the care and use of animals in research in Sri Lanka and in establishing a ‘culture of care for animal research through harmonization’. She was the key player of the training workshop on Animal Ethics held in the University of Colombo in January 2020, where key stakeholders dealing with animal experimentation and ethics at educational and research institutes across Sri Lanka participated.

Dr. Thoradeniya has broad research interests in nutrition modulation of chronic disease risk and the metabolism and functionality of micronutrients, and animal welfare and alternatives. Her research work has been published in several peer-reviewed scientific journals and she has presented her work and provided expertise at conferences, symposia and workshops. Dr. Thoradeniya has received many awards and honours, including the Presidential Research Award, National Consultative Award- International Atomic Energy Authority (IAEA) and has won many competitive travel awards/scholarships including IUBMB Women in Science travel grant. She received Commonwealth Academic Fellowship in 2014 and has participated at Erasmus+ staff mobility for teaching programme in 2017. 

IMG-20200129-WA0012

Dr. Suresh Poosala

Dr. Suresh Poosala is the Founder and President of OncoSeek Bio Pvt Ltd; Board of Directors, Reagene Biosciences; Advisor to The Jackson Laboratory; Council Member, AAALAC International,  Strategic Advisor, Science in India, The Jackson Laboratory, USA  Committee member-Antibiotic Residues, FSSAI, GOI, India  Consultant for in vivo Regulatory and Facilities Accreditations, Pacific Rim Executive Member, Federation of Asian Biologists Association (FABA). He is a leader, scientist and motivator with three decades of international experience in fostering science, innovation and collaborative culture, by building and nurturing high-performing teams.  His career spans scientific excellence in discovery and research, which resulted in high impact publications in high visibility international journals including Nature and he created exceptional quality in vivo facilities and created trained teams for R&D. He has succeeded as a leader in enabling great collaborations between CROs and Discovery programs, academia and industry, and between many strategic partners.  He returned to India after 25 years at NIH, Washington, Bristol-Myers Squibb, San Francisco, University of Maryland, Baltimore, and St. Jude’s Research, Memphis.  He launched a startup after his return to India and is participating in several active advisory roles and partnerships, his way of giving back to Science in India.

Leslie Retnam

Leslie Retnam is currently the Director of Veterinary Services at Biological Resource Centre (BRC), Agency for Science, Research and Technology (A*STAR), Singapore. He is a Council Member with the AAA. He is also Attending Veterinarian for the Animal Care and Use Program at the Biomedical Sciences Institutes (BMSI), A*STAR. Since 2003, he has been a member of Singapore’s National Advisory Committee on Laboratory Animal Research (NACLAR), whose charge is to recommend guidelines for the care and use of animals for scientific purposes in Singapore. He chairs the NACLAR Subcommittee on Training. Since 2006, he has served with AAALAC-I, first as Ad Hoc site visitor and then as Council Member in 2009. He was Assistant Section Leader in 2013 and Section Leader in 2014 and 2015 for the Pacific Rim Section. He is also presently a member of the Ministry of Health’s Expert Subcommittee for Restricted Human Biomedical Research, Singapore’s Accreditation Council, and Chair of the Good Laboratory Practice (GLP) Council Committee.

IMG-20200211-WA0016

Mr. Manu Jaggi

Mr. Manu Jaggi is Chief Operating Officer at Dabur Research Foundation

Watch this space for More updates